Home Faculty |
Faculty
Dr. Knudson's research interest revolves around the regulation of Programmed Cell Death (PCD) by the Bc1-2 Family of Proteins. Aberrant regulation of PCD results in diverse defects ranging from cancer to infertility to neurodegeneration. The focus of the lab is to understand the biochemical basis for Bc1-2 activity and study it's role in development and disease. CLINICAL AND TEACHING LECTURES (To read the following lectures, Adobe Acrobat 5.0 is recommended) New Advances and Approaches in Blood Management (August 24, 2005) Part III: Apoptosis and Cancer (February 25, 2003) Part II: Apoptosis (February 20, 2003) Part I: Apoptosis or Programmed Cell Death (February 18, 2003) Therapeutic Hemopheresis-General overview. Evidence Based Medicine (August 28, 2002) Part II: Apoptosis and Cancer (May 25, 2002) Part I: Overview of Apoptosis or Programmed Cell Death (May 23, 2002) Donor Infectious Disease Testing (methods, interpretation, re-entry) (August 1, 2001) Overview of Apoptosis or Programmed Cell Death (March 7, 2001) Part II: Apoptosis and Cancer (February 27, 2001) Part I: Overview of Apoptosis or Programmed Cell Death (February 22, 2001) Donor Infectious Disease Testing (methods, interpretation, re-entry) (August 16, 2000) New Insights into the Patogenesis of Thrombotic Thrombocytopenic Purpura (TTP) (June 9, 2000) Future Role of Genome Amplification Testing in Transfusion Medicine (February 1999) VIEW PUBLICATIONS |
||
